Una S Ryan's Net Worth
$33.7 Million
Who is Una S Ryan?
Una S Ryan has an estimated net worth of $33.7 Million. This is based on reported shares across multiple companies, which include RenovoRx, Inc., Quince Therapeutics, Inc., ALBANY MOLECULAR RESEARCH INC, and AVANT IMMUNOTHERAPEUTICS INC.
SEC CIK
Una S Ryan's CIK is 0001255349
Past Insider Trading and Trends
2008 was Una S Ryan's most active year for acquiring shares with 8 total transactions. Una S Ryan's most active month to acquire stocks was the month of May. 2016 was Una S Ryan's most active year for disposing of shares, totalling 2 transactions. Una S Ryan's most active month to dispose stocks was the month of September. 2008 saw Una S Ryan paying a total of $5,141,642.50 for 624,650 shares, this is the most they've acquired in one year. In 2017 Una S Ryan cashed out on 5,000 shares for a total of $72,350.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RenovoRx, Inc. (RNXT) Snapshot price: $1.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quince Therapeutics, Inc. (QNCX) Snapshot price: $1.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 2.88K |
$17.00 | $48,875.00 | 2.88K |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBANY MOLECULAR RESEARCH INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.67% | 5K |
$14.47 | $72,350.00 | 51.84K |
May 10
| |||
Form 4
| +8.83% | 3.8K |
—
|
—
| 46.84K |
Feb 8
| |||
Form 4
| +3.62% | 1.5K |
$14.37 | -$1.18 | 43.04K |
Oct 5
| |||
Form 4
| +10.80% | 4.05K |
$14.82 | $59,991.36 | 41.54K |
Jun 15
| |||
Form 4
| +8.24% | 2.85K |
$15.77 | $45,007.58 | 37.49K |
Feb 4
| |||
Form 4
| +3.36% | 1.13K |
$19.98 | $22,497.48 | 34.64K |
Jun 12
| |||
Form 4
| +8.55% | 2.64K |
$17.05 | $44,994.95 | 33.51K |
Mar 2
| |||
Form 4
| +12.20% | 3.36K |
$10.43 | $35,003.08 | 30.87K |
Feb 4
| |||
Form 4
| +5.50% | 1.43K |
$10.46 | $14,999.64 | 27.52K |
Jun 5
| |||
Form 4
| +28.87% | 5.84K |
$5.99 | $34,999.57 | 26.08K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +44.40% | 6.22K |
$2.41 | $14,999.84 | 20.24K |
Jun 6
| |||
Form 4
| +1.45% | 200 |
$2.81 | $562.00 | 14.02K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +26.77% | 2.92K |
$5.14 | $14,998.52 | 13.82K |
Jun 1
| |||
Form 4
| +28.83% | 2.44K |
$6.15 | $14,999.85 | 10.9K |
Jun 2
| |||
Form 4
| +25.18% | 1.7K |
$8.81 | $14,994.62 | 8.46K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +46.66% | 2.15K |
$13.95 | $29,992.50 | 6.76K |
Jun 4
| |||
Form 4
| +81.78% | 2.07K |
$14.47 | $29,996.31 | 4.61K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.54K |
$11.83 | $29,989.05 | 2.54K |
Oct 30
| |||
| No matching records found | |||||||||
AVANT IMMUNOTHERAPEUTICS INC (CLDX) Snapshot price: $38.16
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +0.06% | 500 |
$0.71 | $352.75 | 899.21K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +3.49% | 30.3K |
$1.36 | $41,056.50 | 898.71K |
Aug 16
| |||
Form 4
| +0.06% | 500 |
$1.37 | $684.50 | 868.41K |
Jul 3
| |||
Form 4
| +0.06% | 500 |
$1.04 | $518.50 | 867.91K |
Jan 3
| |||
Form 4
| +23.06% | 200K |
—
|
—
| 1.07M |
Sep 21
| |||
Form 4
| +0.06% | 500 |
$1.71 | $854.50 | 867.41K |
Dec 31
| |||
Form 4
| +85.67% | 400K |
—
|
—
| 866.91K |
Nov 5
| |||
Form 4
| +2.19% | 10K |
$1.87 | $18,708.73 | 466.91K |
Aug 3
| |||
Form 4
| +702.83% | 400K |
—
|
—
| 456.91K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||